Dorothe Spillmann

Dorothe Spillmann serves as a Senior Lecturer at the Department of Medical Biochemistry and Microbiology within the Faculty of Medicine at Uppsala University. With a research career spanning several decades, she has established herself as a prominent figure in glycobiology with particular expertise in glycosaminoglycan structure and function.

Dr. Spillmann's research focuses on the structural and functional aspects of heparan sulfate and chondroitin sulfate, examining how specific modifications to these molecules influence cellular processes. Her work bridges fundamental biochemistry with clinical applications, particularly in cancer biology where she investigates how glycosaminoglycan alterations affect tumor progression, metastasis, and cellular signaling pathways. She has made significant contributions to understanding the role of specific sulfation patterns in cell behavior, especially in melanoma and breast cancer contexts.

Analysis of her publication record reveals a consistent trajectory of high-impact research in glycosaminoglycan biology. Her most recent work examines transcriptomic changes in melanoma cells modified by heparanase, the role of chondroitin sulfate in regeneration processes, and how specific enzymes that modify heparan sulfate affect cancer cell migration. Her research demonstrates expertise across multiple methodologies including molecular biology, biochemical analysis, and mass spectrometry-based approaches for characterizing glycosaminoglycan structures.

Dr. Spillmann has maintained extensive collaborative networks both within Uppsala University and internationally, contributing to diverse research projects that examine glycosaminoglycan biology in cancer, development, and infectious disease contexts. Her work continues to advance our understanding of how these complex carbohydrates regulate fundamental cellular processes with implications for human health and disease.